New opportunities in the treatment of cutaneous lymphoid hyperplasia

Cover Page

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Here, we present the results of our research regarding the efficacy of photodynamic therapy (PDT) in cutaneous lymphoid hyperplasia (CLH). We observed five patients with CLH. The diagnoses were confirmed both clinically and through laboratory testing. The response to treatment was defined by the index of the modified assessment of the severity of the skin lesions scale (mSWAT). PDT (665 ± 10 nm) with topical photosensitizer application was performed once a week. The PDT course consisted of 4 ± 2 sessions. After the therapy, complete remission was achieved in four patients (80%; mSWAT 95–100%) and partial remission in one patient (20%; mSWAT 63%). Thus, PDT proved to be an effective and safe method for treating CLH.

Full Text

Restricted Access

About the authors

O. Yu. Olisova

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Author for correspondence.
Email: olisovaolga@mail.ru
ORCID iD: 0000-0003-2482-1754

MD, PhD, DSc, Head of Department of Dermatology and Venereology

Russian Federation, Moscow, 119991

E. M. Anpilogova

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Email: olisovaolga@mail.ru
ORCID iD: 0000-0001-9478-5838

Department of Dermatology and Venerology

Russian Federation, Moscow, 119991

References

  1. Olisova O.Yu., Potekaev N.S. Cutaneous pseudolymphomas (etiology, clinical picture, diagnosis and treatment). Manual for physicians. Moscow: Medical Center of the Presidential Executive Office of Russian Federation; 2002. (in Russian)
  2. Nihal M., Mikkola D., Horvath N., Gilliam A., Stevens S., Spiro T., et al. Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential. Hum. Pathol. 2003; 34(6):617-22. doi: 10.1016/s0046-8177(03)00075-3.
  3. Tomar S., Stoll H., Grassi M., Cheney R. Treatment of cutaneous pseudolymphoma with interferon alfa-2b. J. Am. Acad. Dermatol. 2009; 60(1):172-4. doi: 10.1016/j.jaad.2008.07.052.
  4. Stoll D. Treatment of cutaneous pseudolymphoma with hydroxychloroquine. J. Am. Acad. Dermatol. 1983; 8(5):696-9.
  5. El-Dars L., Statham B., Blackford S., Williams N. Lymphocytoma cutis treated with topical tacrolimus. Clin. Exp. Dermatol. 2005; 30(3):305-7.
  6. Martin S., Duvic M. Treatment of cutaneous lymphoid hyperplasia with the monoclonal anti-CD20 antibody rituximab. Clin. Lymphoma Myeloma Leuk. 2011; 11(3):286-8. doi: 10.1016/j.clml.2011.03.017.
  7. Dionyssopoulos A., Mandekou-Lefaki I., Delli F., Kourtis D., Nikolis A., Dionyssopoulou E. T- and B-cutaneous pseudolymphomas treated by surgical excision and immediate reconstruction. Dermatol. Surg. 2006; 32(12):1526-9.
  8. Taylor R., Fortney J., Pollack R., Metcalf J., Jenrette J. Radiation therapy for B-cell cutaneous lymphoid hyperplasia. Jpn. J. Radiol. 2010; 28(5):385-7. doi: 10.1007/s11604-010-0439-8
  9. Oliveira E., Badiale G., Moraes M. Lymphocytoma cutis: Case report. An Bras. Dermatol. 2013; 88(6, Suppl. 1):128-31. doi: 10.1590/abd1806-4841.20132320.
  10. Mikasa K., Watanabe D., Kondo C., Tamada Y., Matsumoto Y. Topical 5-aminolevulinic acid-based photodynamic therapy for the treatment of a patient with cutaneous pseudolymphoma. J. Am. Acad. Dermatol. 2005; 53(5):911-2.
  11. Takeda H., Kaneko T., Harada K., Matsuzaki Y., Nakano H., Hanada K. Successful treatment of lymphadenosis benigna cutis with topical photodynamic therapy with delta-aminolevulinic acid. Dermatology. 2005; 211(3):264-6.
  12. O’Neill J., Fien S., Zeitouni N. ALA-PDT for the treatment of cutaneous pseudolymphoma: a case report. J. Drugs. Dermatol. 2010; 9(6):688-9.

Supplementary files

Supplementary Files
Action
1. Fig. 1. Patient K., 70 years old (see table). Benign skin lymphoplasia after hirudotherapy. a - before treatment; b - after 4 sessions of photodynamic therapy.

Download (1MB)
2. Fig. 2. Patient L., 71 years old (see table). Benign skin lymphoplasia, postscabious. a - before treatment; b - after 3 sessions of photodynamic therapy.

Download (1MB)
3. Fig. 3. Clinical response in patients with benign skin lymphoplasia to photodynamic therapy (in%).

Download (562KB)

Statistics

Views

Abstract: 284

Dimensions

Article Metrics

Metrics Loading ...

PlumX


Copyright (c) 2020 Eco-Vector



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies